Jun 12 2018

Pharmaceutical Microbiology, pharmaceutical industry data.#Pharmaceutical #industry #data

Pharmaceutical Microbiology

Microbiology, pharmaceuticals, healthcare and contamination control news and discussion site. Edited by Dr. Tim Sandle (established 2010)


Pharmaceutical industry data

Wednesday, 22 November 2017

Justification of starting materials for the manufacture of chemical active substances

Pharmaceutical industry data

Tuesday, 21 November 2017

Q Pharmig20 and you or your company will be invoiced accordingly.

Microbial Control of Pharmaceutical Water Systems

Pharmaceutical industry data

Sunday, 19 November 2017

Biocidal cleaners may spread multidrug resistance in MRSA

Pharmaceutical industry data

Saturday, 18 November 2017

Examining the lifestyles of microbes

Pharmaceutical industry data

Friday, 17 November 2017

Bacterial signalling in sharper resolution

Pharmaceutical industry data

Thursday, 16 November 2017

ISO/IEC 17025 moves to final stage of revision

Pharmaceutical industry data

Wednesday, 15 November 2017

Past, present, and future perspectives on the LAL reagent

Q A covering past, present, and future perspectives on the LAL reagent

Pharmaceutical industry data

JD: Actually, we use all four methods: gel-clot, kinetic turbidimetric, kineticchromogenic and the PTS . These methods are used to test and release incoming raw materials and to evaluate intermediate formulation buffers that are subsequently used to produce licensed LAL products. Our accessory products also benefit from the use of these methods prior to release. Finally, we leverage all of these techniques in developing and validating LAL test methods for customer-specific products.

How did the introduction of the LAL test change our industry?

What are the key trends in endotoxin and LAL testing? What advances have been made?

What new challenges will be faced in the years to come?

Written by admin

Leave a Reply

Your email address will not be published. Required fields are marked *